New Generation Rehabilitation Approach in Children With Dysfunctional Voiding
1 other identifier
interventional
38
1 country
1
Brief Summary
The investigators hypothesize that Dynamic Neuromuscular Stabilization training, a next-generation exercise approach, and transabdominal ultrasound-guided pelvic floor muscle training (PFMT) will be more effective than PFMT guided solely by transabdominal ultrasound in reducing post-void residual volume, improving voiding disorder symptoms, and enhancing pelvic floor muscle relaxation in children with dysfunctional voiding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2024
CompletedFirst Posted
Study publicly available on registry
December 19, 2024
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedFebruary 6, 2026
February 1, 2026
1 year
December 16, 2024
February 4, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Change in the amount of post-void residue
After EMG-Uroflowmetry test: Post-void residual measurement will be made by transabdominal ultrasound 5 minutes after voiding. In repeated measurements, the amount of urine remaining in the bladder of 20 ml or more will be considered pathological.
From enrollment to the end of treatment at 8 weeks
Change in EMG-Uroflowmetry measurements-peak flow rate
EMG-Uroflowmetry test procedure: Before the test, the device will be calibrated and the scale of the interpretation sheet will be set to 1:1 for flow rate (ml/sec) and time (sec). The test will be performed in a quiet and private room and the patient will be asked to drink as much fluid as the expected bladder capacity ((age in years+1)x30) 1 hour before the test. During the test, the EMG activity of the pelvic floor muscles will also be evaluated. Voided volume (ml), peak flow rate (Q max, ml/sec) and uroflow curve interpretation will also be used. Those with decreased flow rate and stacco/interminant flow pattern will be considered pathological.
From enrollment to the end of treatment at 8 weeks
Change in EMG-Uroflowmetry measurements-Pelvic Floor EMG activity
EMG-Uroflowmetry test procedure: Before the test, the device will be calibrated and the scale of the interpretation sheet will be set to 1:1 for flow rate (ml/sec) and time (sec). The test will be performed in a quiet and private room and the patient will be asked to drink as much fluid as the expected bladder capacity ((age in years+1)x30) 1 hour before the test. During the test, the EMG activity of the pelvic floor muscles will also be evaluated. Recorded as (µV).
From enrollment to the end of treatment at 8 weeks
Secondary Outcomes (11)
Change in EMG-Uroflowmetry measurements-uroflow curve
From enrollment to the end of treatment at 8 week
Change in EMG-Uroflowmetry measurements - Voided volume
From enrollment to the end of treatment at 8 weeks
Pelvic floor muscle assessment with ultrasound - maximum displacement (cm)
From enrollment to the end of treatment at 8 weeks
Pelvic floor muscle assessment with ultrasound - coordination amplitude (cm)
From enrollment to the end of treatment at 8 weeks
Pelvic floor muscle assessment with ultrasound - endurance amplitude (%)
From enrollment to the end of treatment at 8 weeks
- +6 more secondary outcomes
Study Arms (2)
DNS Group
EXPERIMENTALThis group includes 18 children with Dysfunctional voiding, aged between 6 and 14 years.
Standard exercise group
ACTIVE COMPARATORThis group includes 18 children with Dysfunctional voiding, aged between 6 and 14 years.
Interventions
Pelvic floor muscle training (PFMT) will be given to both groups with transabdominal US. PFMT will be applied by physiotherapists who have received training and supervision from physiotherapists who are experts in the field of pelvic floor US imaging and pelvic floor muscle training with US. Pelvic floor muscle training will be applied with a GE Brand LOGIQ P8 model transabdominal ultrasound (GE HealthCare) US device under the supervision of an expert physiotherapist. Parents and children will be informed about PFMT.
Dynamic neuromuscular exercises (DNS) involve the joint activation of the intrinsic muscle group of the spine, which includes the cervical flexors and extensors, diaphragm, transversus abdominis, multifidus and pelvic floor, which form the integrated spinal stabilization system. The application principles are joint centering, core stabilization - Integrated spinal stabilization system and stabilization function of the diaphragm. DNS training will be applied in three stages. Preparation for exercises, IAB regulation and application of exercises according to developmental kinesiology positions. Exercises will start with preparatory training. In preparatory training, stroking, brushing and tapping techniques will be taught and self-facilitation will be demonstrated in order to increase proprioceptive input to the lower extremity, upper extremity, trunk and pelvic region. Fascial mobilizations will be performed to the foot and hand regions.
Eligibility Criteria
You may qualify if:
- Children aged 6-14 years,
- Diagnosed with dysfunctional urination according to uroflowmetry measurement results and clinical examination findings,
- Children who consent to participate in the study with the consent of their mother, father or legal guardian (legal representative) will be included in the study.
You may not qualify if:
- Children under 6 years of age,
- Those with anatomical changes in the urinary system,
- Those with spina bifida,
- Those with a history of active urinary tract infection,
- Those with a neurological disease,
- Those with accompanying respiratory system disease,
- Those with cognitive impairment,
- Those with mental retardation,
- Children whose bladder image is unclear in the pelvic floor evaluation with US,
- Children who have previously undergone orthopedic surgery will not be included in the study.
- PS:
- Children who cannot comply with the application of pelvic floor muscle training,
- Children who have missed 2 or more sessions of the treatment program will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Izmir University of Economicslead
- Health Institutes of Turkeycollaborator
Study Sites (1)
Izmir University of Economics
Izmir, 35330, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Seda Yakıt Yeşilyurt, Asst. Prof.
Izmir University of Economics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof.
Study Record Dates
First Submitted
December 16, 2024
First Posted
December 19, 2024
Study Start
February 1, 2025
Primary Completion
February 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
February 6, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Since no consent has been received from the institutions supporting this project to share the data with third parties, it will not be shared.